Literature DB >> 9535784

Striking evolutionary conservation of a cis-element related to nuclear receptor target sites and present in TR2 orphan receptor genes.

C Le Jossic1, D Michel.   

Abstract

A systematic scanning of nucleic acid databases for DNA elements made of combinations of RGGTCA nuclear receptor half sites, has revealed that identical 19 nucleotide-long motifs composed of two inverted RGGTCA sites with a spacing of 7 nucleotides (IR7), are present upstream of the regions coding for the human TR2 and of the sea urchin SpSHR2 orphan receptors. We have developed an experimental strategy based on PCR, to check if this IR7 could correspond to an unusually long cis-element, conserved along evolution and regulating the TR2 genes. We found that indeed IR7 is present in the 5' untranslated region of TR2 genes from all species tested, including Xenopus, rainbow trout, zebrafish and mouse. The exact conservation throughout the animal kingdom of such a long, non repetitive and non coding genomic region, highly suggests that it should ensure important biological functions. In addition, this work has allowed the identification of a new, non coding, upstream exon in the mouse TR2 gene present in testicular TR2 mRNAs. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9535784     DOI: 10.1006/bbrc.1998.8376

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Nuclear receptors are markers of animal genome evolution.

Authors:  Hector Escrivá García; Vincent Laudet; Marc Robinson-Rechavi
Journal:  J Struct Funct Genomics       Date:  2003

2.  Cloning and characterization of mouse RIP140, a corepressor for nuclear orphan receptor TR2.

Authors:  C H Lee; C Chinpaisal; L N Wei
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

Review 3.  Nuclear Receptors as Potential Therapeutic Targets for Myeloid Leukemia.

Authors:  Pan Pan; Xiao Chen
Journal:  Cells       Date:  2020-08-19       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.